Close Menu

NEW YORK (GenomeWeb) – Scientists from AstraZeneca, Waters, and Labcyte have developed a mass spectrometry system capable of running 100,000 samples per day.

AstraZeneca researchers are currently using the system for high-throughput drug candidate screening assays and metabolomic profiling, said Jonathan Wingfield, principal scientist at the drug company and senior author on an Analytical Chemistry paper published this month describing the system.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.